FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

Support for FDA Biosimilar Comparative Studies Draft Guidance

Four drug industry stakeholders say they support an FDA draft guidance proposing to reduce reliance on comparative efficacy studies when determining b...

latest-news-card-1
Human Drugs

FDA Soliciting PreCheck Pilot Applications

FDA says it will start accepting applications on 2/1 for its new PreCheck Pilot program intended to boost domestic drug manufacturing capability.

latest-news-card-1
Human Drugs

FDA Push to Move More Drugs to OTC Status

FDA commissioner Marty Makary discusses upcoming actions to encourage more prescription-to-over-the-counter drug switches.

latest-news-card-1
Human Drugs

Cogent Bio Plans NDA for Bezuclastinib

Cogent Biosciences says FDA has agreed to accept the companys planned NDA for cancer drug bezuclastinib under the agencys Real-Time Oncology Review pr...

latest-news-card-1
Human Drugs

FDA Touts ImportShield Results

FDA says its new ImportShield program improved processing speed and volume capacity while reducing staff hours in its first four months in operation.

latest-news-card-1
Medical Devices

AdvaMed Urges FDA to Narrow Guidance on Device QMS

Advanced Medical Technology Association urges FDA to narrow and clarify a draft guidance on quality management system information, warning that the cu...

latest-news-card-1
Biologics

Moderna/Merck Report Positive Data on Melanoma Vaccine

Moderna and Merck report updated five-year follow-up data that show their personalized mRNA cancer vaccine candidate, intismeran autogene, significant...

Human Drugs

Objectionable Conditions in Prodrome Sciences BIMO Inspection

FDA warns Temecula, CA-based Prodrome Sciences USA about violations in its conduct of a clinical trial without submitting an IND.

latest-news-card-1
Human Drugs

Guide on Endpoints for Multiple Myeloma Accelerated Approval

FDA posts a draft guidance outlining how drug developers can use minimal residual disease and complete response as primary endpoints in multiple myelo...

latest-news-card-1
Human Drugs

Novo Nordisk Supplements Semaglutide Petition

Novo Nordisk submits to FDA additional studies and analyses it says support its petition asking the agency to act against compounded forms of its sema...